Danielle Antalffy
Stock Analyst at UBS
(3.82)
# 704
Out of 5,090 analysts
191
Total ratings
51.82%
Success rate
8.66%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Neutral | $90 → $92 | $86.19 | +6.74% | 13 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Neutral | $95 → $102 | $101.36 | +0.63% | 12 | Nov 19, 2025 | |
| PODD Insulet | Upgrades: Buy | $355 → $400 | $304.49 | +31.37% | 13 | Nov 19, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $6.5 → $5.85 | $2.74 | +113.50% | 8 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $96 → $88 | $94.28 | -6.66% | 6 | Nov 6, 2025 | |
| INMD InMode | Maintains: Neutral | $16 → $16 | $14.42 | +10.96% | 5 | Nov 6, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 → $95 | $65.49 | +45.06% | 10 | Nov 3, 2025 | |
| BAX Baxter International | Maintains: Neutral | $24 → $21 | $18.54 | +13.27% | 7 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $585 → $600 | $575.34 | +4.29% | 3 | Oct 23, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $135 → $140 | $97.52 | +43.56% | 14 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $214 | $201.93 | +5.98% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $230 → $89 | $136.81 | -34.95% | 7 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $8 | $12.63 | -36.66% | 4 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $57 | $27.02 | +110.95% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $20.92 | -18.74% | 15 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $134 | $108.51 | +23.49% | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $39.86 | +45.51% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $5 | $8.05 | -37.89% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $125.08 | +18.32% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $364.02 | +1.64% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $3.06 | -26.47% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $4.39 | +18,692.71% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $33.32 | -57.98% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $63.30 | +57.98% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $16.40 | -26.83% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $30 | $35.86 | -16.34% | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $36.23 | +24.21% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $193.96 | +41.78% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $4.74 | +321.94% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $6.94 | +505.19% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $60 | $6.62 | +806.34% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.73 | +1,954.51% | 1 | Sep 1, 2020 |
Edwards Lifesciences
Dec 5, 2025
Maintains: Neutral
Price Target: $90 → $92
Current: $86.19
Upside: +6.74%
Medtronic
Nov 19, 2025
Maintains: Neutral
Price Target: $95 → $102
Current: $101.36
Upside: +0.63%
Insulet
Nov 19, 2025
Upgrades: Buy
Price Target: $355 → $400
Current: $304.49
Upside: +31.37%
Treace Medical Concepts
Nov 7, 2025
Maintains: Neutral
Price Target: $6.5 → $5.85
Current: $2.74
Upside: +113.50%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Sell
Price Target: $96 → $88
Current: $94.28
Upside: -6.66%
InMode
Nov 6, 2025
Maintains: Neutral
Price Target: $16 → $16
Current: $14.42
Upside: +10.96%
DexCom
Nov 3, 2025
Maintains: Buy
Price Target: $106 → $95
Current: $65.49
Upside: +45.06%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $24 → $21
Current: $18.54
Upside: +13.27%
Intuitive Surgical
Oct 23, 2025
Maintains: Neutral
Price Target: $585 → $600
Current: $575.34
Upside: +4.29%
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $135 → $140
Current: $97.52
Upside: +43.56%
Oct 14, 2025
Maintains: Buy
Price Target: $190 → $214
Current: $201.93
Upside: +5.98%
Sep 22, 2025
Downgrades: Neutral
Price Target: $230 → $89
Current: $136.81
Upside: -34.95%
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $12.63
Upside: -36.66%
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $27.02
Upside: +110.95%
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $20.92
Upside: -18.74%
Jul 31, 2025
Maintains: Buy
Price Target: $125 → $134
Current: $108.51
Upside: +23.49%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $39.86
Upside: +45.51%
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $8.05
Upside: -37.89%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $125.08
Upside: +18.32%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $364.02
Upside: +1.64%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $3.06
Upside: -26.47%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $4.39
Upside: +18,692.71%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $33.32
Upside: -57.98%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $63.30
Upside: +57.98%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $16.40
Upside: -26.83%
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $35.86
Upside: -16.34%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $36.23
Upside: +24.21%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $193.96
Upside: +41.78%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $4.74
Upside: +321.94%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $6.94
Upside: +505.19%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $60
Current: $6.62
Upside: +806.34%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.73
Upside: +1,954.51%